Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Amr Salahieh on the Keys to Successful Entrepreneurship

February 27, 2024


Starting a company is an intimidating feat. Starting multiple companies is even scarier. In this month’s episode of Medtech Talk, host Geoff Pardo speaks with Amr Salahieh, founder and CEO of Shifamed, about his extensive experiences of entrepreneurship in the medtech ecosystem. As the founder of several companies, including Sadra Medical, Maya Medical, and Apama Medical, Salahieh shares his tips and tactics on finding the right markets, taking care of your investors, and overcoming challenges when a company fails. He also offers his thoughts on the biggest obstacle in the medtech sector today and how Shifamed has remained sustainable compared to other organizations.


Amr Salahieh

founder and CEO


Amr is a seasoned medical device entrepreneur with over 30 years of healthcare experience. He is the founder and CEO of Shifamed LLC, a successful and well-established medical innovation hub headquartered in the heart of Silicon Valley. Legacy portfolio companies that Amr has been a CEO, Founder and Chairman of include Embolic Protection Inc. (acquired by Boston Scientific, 2001), Sadra Medical (acquired by Boston Scientific, 2011), Maya Medical (acquired by Covidien, 2012), Kalila Medical (acquired by Abbott, 2016), Apama Medical (acquired by Boston Scientific, 2017) and NuVera Medical (acquired by Biosense Webster, a Johnson & Johnson company, 2020).

Shifamed and its dedicated management team has raised over $400 million to date across the current portfolio companies. Current portfolio companies include five focused in cardiovascular, two in the ophthalmology space, and one SaaS company. All portfolio companies are initiated, funded, and operated by Shifamed, with Amr serving as the Chairman of the Board. Each company is an independent Delaware entity, led by an experienced CEO, with a focused team and strategically structured for rapid integration upon acquisition. To date, Shifamed has grown to over 300 U.S. employees across an eight-building campus with an additional 50 employees located outside of the United States.

Shifamed has over 450 U.S. patent applications pending and more than 100 issued worldwide, with Amr as either the inventor or co-inventor on over 200. Amr holds a B.S. in Biomedical Engineering and a B.S. in Electrical Engineering from Case Western Reserve University

Meet Our Host, Geoff Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.